Welcome to our dedicated page for Piper Sandler Co`S SEC filings (Ticker: PIPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Piper Sandler Companies filings document the regulatory record of an investment bank and institutional securities firm listed on the New York Stock Exchange. Current reports disclose quarterly and annual operating results, dividends, capital actions, and other material events tied to the company’s advisory, capital markets, public finance, brokerage, research, fixed income, and asset management activities.
The company’s proxy materials cover annual meeting matters, board structure, governance practices, executive and director compensation, shareholder voting, and capital return disclosures. Recent 8-K filings also document director elections, committee appointments, and certificate amendments related to the completed four-for-one forward stock split and related authorized-share changes.
TAYLOR SCOTT C reported acquisition or exercise transactions in this Form 4 filing.
Piper Sandler Companies director Scott C. Taylor received an equity-based award linked to 1,875 shares of common stock. The filing shows the award at a price of $0.00 per share as a grant, not an open-market purchase or sale. Following this transaction, his directly held common stock position is reported at 67,927 shares.
According to the footnote, Taylor elected to defer this annual equity grant into 1,875 shares of phantom stock, which will be paid out in common stock on the last day of the year in which his service as a director ends.
Piper Sandler Companies director Brian R. Sterling reported an acquisition of company stock. On May 20, he received 1,875 shares of Common Stock in a transaction classified as a grant or award at a stated price of $0.00 per share. Following this award, he directly holds 104,534 shares of Piper Sandler common stock.
Piper Sandler Companies director Philip Soran reported a compensation-related stock award. He acquired 1,875 shares of common stock in the form of an annual equity grant, which he elected to defer into 1,875 shares of phantom stock credited to his account.
After this grant, Soran directly holds 81,082 shares of common stock. The phantom stock will be settled in common stock and become payable on the last day of the year in which his service as a director ends. This is a non-cash award and not an open-market purchase or sale.
SCHREIER THOMAS S JR reported acquisition or exercise transactions in this Form 4 filing.
Piper Sandler Companies director Thomas S. Schreier Jr. received a grant of 1,875 shares of common stock on May 20, 2026. The shares were awarded at a reported price of $0.00 per share, indicating an equity compensation grant rather than an open-market purchase. Following this award, he directly holds a total of 32,479 Piper Sandler common shares.
Mitchell Robbin reported acquisition or exercise transactions in this Form 4 filing.
PIPER SANDLER COMPANIES director Mitchell Robbin reported a deferred equity award. The director elected to defer an annual equity grant of 1,875 shares of common stock, which accrued as 1,875 shares of phantom stock in the director's account. These phantom shares will be paid out in common stock on the last day of the year in which the director's board service ends. Following this grant, the director directly holds 15,715 shares of Piper Sandler common stock.
Director Victoria M. Holt of Piper Sandler Companies received an award linked to 1,875 shares of common stock on May 20, 2026. She elected to defer this annual equity grant, so it was credited as 1,875 shares of phantom stock in her account rather than current shares.
These phantom shares will be paid out in common stock on the last day of the year in which her board service ends. After this grant, Holt’s reported direct holdings total 31,787 shares of common stock, reflecting a routine, compensation-related acquisition rather than an open-market trade.
ESSIG STUART reported acquisition or exercise transactions in this Form 4 filing.
Piper Sandler Companies director Stuart Essig received a stock grant of 1,875 shares of common stock. The award was reported at a price of $0.00 per share, indicating a compensation-related grant rather than an open-market purchase. After this grant, he directly holds 2,575 shares of Piper Sandler common stock.
Piper Sandler Companies director Ann C. Gallo reported a compensation-related award involving 1,875 shares. On this Form 4, she is shown acquiring 1,875 shares at a price of $0.00 per share, with her direct common stock holdings reported at 7,706 shares after the transaction.
According to the footnote, she elected to defer receipt of an annual equity grant, resulting in an accrual of 1,875 shares of phantom stock in her account. These phantom shares will be paid out in common stock on the last day of the year in which her service as a director ends, making this a standard deferred equity compensation arrangement rather than an open-market purchase or sale.
Piper Sandler Companies reported the results of its annual shareholder meeting held on May 20, 2026. Shareholders representing 59,916,900 common shares, or 84.07 percent of shares entitled to vote as of the record date, were present in person or by proxy.
All ten nominated directors, including Chad R. Abraham, Jonathan J. Doyle and Scott C. Taylor, were elected to one-year terms expiring at the 2027 annual meeting. Each director received over 53.9 million votes in favor, with broker non-votes of 4,188,050 for each seat.
Shareholders also approved the ratification of Ernst & Young LLP as independent auditor for the fiscal year ending December 31, 2026, with 58,666,911 votes for and 1,165,687 against. In an advisory say-on-pay vote, shareholders approved the executive compensation program, with 55,063,759 votes for and 534,421 against, plus 4,188,050 broker non-votes.
Piper Sandler Companies reported solid first‑quarter 2026 results with stronger revenue and stable earnings. Total revenues rose to $475.1 million from $358.6 million a year earlier, driven mainly by investment banking revenue of $348.2 million and institutional brokerage revenue of $110.8 million. Net income attributable to Piper Sandler was $65.2 million, roughly flat with $64.9 million, as higher compensation and other operating expenses offset much of the revenue growth. Diluted earnings per share were $0.92 versus $0.91. Cash and cash equivalents decreased to $344.4 million from $809.4 million at year‑end as the company used cash for operations, dividends and share repurchases. The firm paid $100.7 million of dividends, including a $1.25 special dividend, and repurchased $69.9 million of common stock. Piper Sandler remained well capitalized, with $2.13 billion of total assets and broker‑dealer net capital of $276.1 million, far above regulatory minimums.